1
|
Vela-Anero Á, Hermida-Gómez T, Gato-Calvo L, Vaamonde-García C, Díaz-Prado S, Meijide-Faílde R, Blanco FJ, Burguera EF. Long-term effects of hydrogen sulfide on the anabolic-catabolic balance of articular cartilage in vitro. Nitric Oxide 2017; 70:42-50. [PMID: 28821460 DOI: 10.1016/j.niox.2017.08.004] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2017] [Revised: 08/10/2017] [Accepted: 08/12/2017] [Indexed: 12/25/2022]
Abstract
Healthy cartilage maintenance relies on an equilibrium among the anabolic and catabolic processes in chondrocytes. With the onset of osteoarthritis (OA), increased interleukin (IL)-1β levels induce an inhibition of the synthesis of extracellular matrix (ECM) proteins, as well as an increase in proteases. This eventually leads to a predominance of the catabolic phenotype and the progressive loss of articular cartilage. Hydrogen sulfide (H2S) is a small gaseous molecule recognized as the third endogenous gasotransmitter. When administered exogenously, it has shown anti-inflammatory and anti-catabolic properties in several in vitro and in vivo models. Here, OA cartilage disks were co-cultured in vitro with IL-1β (5 ng/ml) and NaSH or GYY4137 (200 or 1000 μM) for 21 days. The ability of these two H2S-producing compounds to avoid long term extracellular matrix (ECM) destruction was evaluated. We used a glycosaminoglycan (GAG) quantification kit histology and immunohistochemistry (IHC) to evaluate matrix proteins degradation and matrix metalloproteinases (MMP) abundance. Through the GAGs quantification assay, safranin O (S-O) and toluidine blue (TB) stains, and keratan/chondroitin sulfate (KS/ChS) IHCs it was shown that co-stimulation with H2S-forming reagents effectively avoided GAGs destruction. Both Masson's trichrome (MT) stain and collagen (col) type II IHC, as well as aggrecan (agg) IHC demonstrated that not only were these proteins protected but even promoted, their abundance being higher than in the basal condition. Further, stains also demonstrated that positivity in the inter-territorial and intra-cellular for the different matrix components were rescued, suggesting that NaSH and GYY4137 might also have pro-anabolic effects. In addition, a clear protective effect against the increased MMPs levels was seen, since increased MMP3 and 13 levels were subsequently reduced with the co-stimulation with sulfide compounds. In general, GYY4137 was more effective than NaSH, and increasing the dose improved the results. This study demonstrates that H2S anti-catabolic effects, which had been previously proven in short-term (24-48 h) in vitro cellular models, are maintained over time directly in OA cartilage tissue.
Collapse
Affiliation(s)
- Á Vela-Anero
- Grupo de Terapia Celular y Medicina Regenerativa, Departamento de Ciencias Biomédicas, Medicina y Fisioterapia, Facultad de Ciencias de la Salud, Universidade da Coruña, Instituto de Investigación Biomédica de A Coruña-Complejo Hospitalario Universitario de A Coruña, Servizo Galego de Saúde, A Coruña, Spain; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Grupo de Bioingieneria Tisular y Terapia Celular (GBTTC), Spain.
| | - T Hermida-Gómez
- CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Grupo de Bioingieneria Tisular y Terapia Celular (GBTTC), Spain; Grupo de Investigación en Reumatología, Instituto de Investigación Biomédica de A Coruña-Complejo Hospitalario Universitario de A Coruña, Servizo Galego de Saúde, A Coruña, Spain.
| | - L Gato-Calvo
- Grupo de Investigación en Reumatología, Instituto de Investigación Biomédica de A Coruña-Complejo Hospitalario Universitario de A Coruña, Servizo Galego de Saúde, A Coruña, Spain.
| | - C Vaamonde-García
- Grupo de Terapia Celular y Medicina Regenerativa, Departamento de Ciencias Biomédicas, Medicina y Fisioterapia, Facultad de Ciencias de la Salud, Universidade da Coruña, Instituto de Investigación Biomédica de A Coruña-Complejo Hospitalario Universitario de A Coruña, Servizo Galego de Saúde, A Coruña, Spain.
| | - S Díaz-Prado
- Grupo de Terapia Celular y Medicina Regenerativa, Departamento de Ciencias Biomédicas, Medicina y Fisioterapia, Facultad de Ciencias de la Salud, Universidade da Coruña, Instituto de Investigación Biomédica de A Coruña-Complejo Hospitalario Universitario de A Coruña, Servizo Galego de Saúde, A Coruña, Spain; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Grupo de Bioingieneria Tisular y Terapia Celular (GBTTC), Spain.
| | - R Meijide-Faílde
- Grupo de Terapia Celular y Medicina Regenerativa, Departamento de Ciencias Biomédicas, Medicina y Fisioterapia, Facultad de Ciencias de la Salud, Universidade da Coruña, Instituto de Investigación Biomédica de A Coruña-Complejo Hospitalario Universitario de A Coruña, Servizo Galego de Saúde, A Coruña, Spain.
| | - F J Blanco
- Grupo de Investigación en Reumatología, Instituto de Investigación Biomédica de A Coruña-Complejo Hospitalario Universitario de A Coruña, Servizo Galego de Saúde, A Coruña, Spain.
| | - E F Burguera
- CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Grupo de Bioingieneria Tisular y Terapia Celular (GBTTC), Spain; Grupo de Investigación en Reumatología, Instituto de Investigación Biomédica de A Coruña-Complejo Hospitalario Universitario de A Coruña, Servizo Galego de Saúde, A Coruña, Spain.
| |
Collapse
|